IL313039A - Uses of bicyclic compounds for the treatment of diseases - Google Patents

Uses of bicyclic compounds for the treatment of diseases

Info

Publication number
IL313039A
IL313039A IL313039A IL31303924A IL313039A IL 313039 A IL313039 A IL 313039A IL 313039 A IL313039 A IL 313039A IL 31303924 A IL31303924 A IL 31303924A IL 313039 A IL313039 A IL 313039A
Authority
IL
Israel
Prior art keywords
alkyl
membered
alkenyl
subject
alkynyl
Prior art date
Application number
IL313039A
Other languages
English (en)
Hebrew (he)
Original Assignee
Athira Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Athira Pharma Inc filed Critical Athira Pharma Inc
Publication of IL313039A publication Critical patent/IL313039A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL313039A 2021-12-17 2022-12-16 Uses of bicyclic compounds for the treatment of diseases IL313039A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163290783P 2021-12-17 2021-12-17
US202263312696P 2022-02-22 2022-02-22
PCT/US2022/053113 WO2023114456A1 (en) 2021-12-17 2022-12-16 Uses of bicyclic compounds for the treatment of diseases

Publications (1)

Publication Number Publication Date
IL313039A true IL313039A (en) 2024-07-01

Family

ID=86773494

Family Applications (1)

Application Number Title Priority Date Filing Date
IL313039A IL313039A (en) 2021-12-17 2022-12-16 Uses of bicyclic compounds for the treatment of diseases

Country Status (11)

Country Link
US (1) US20250041307A1 (https=)
EP (1) EP4448100A4 (https=)
JP (1) JP2024546600A (https=)
KR (1) KR20240121239A (https=)
AU (1) AU2022410646A1 (https=)
CA (1) CA3240896A1 (https=)
CL (1) CL2024001748A1 (https=)
IL (1) IL313039A (https=)
MX (1) MX2024005884A (https=)
TW (1) TW202339756A (https=)
WO (1) WO2023114456A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025515045A (ja) * 2022-05-04 2025-05-13 アティラ・ファーマ・インコーポレイテッド 神経炎症病態を治療する方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184223B1 (en) * 1995-10-27 2001-02-06 Molecumetics Ltd. Reverse-turn mimetics and methods relating thereto
AU2003284120A1 (en) * 2002-10-17 2004-05-04 Myriad Genetics, Inc. Reverse-turn mimetics and composition and methods relating thereto
EP2155226A4 (en) * 2007-06-14 2010-07-28 Univ California COMPOUNDS FOR INHIBITING THE PROTEIN AGGREGATION AND METHOD FOR THE PRODUCTION AND USE THEREOF
KR20130139895A (ko) * 2010-09-02 2013-12-23 다케다 야쿠힌 고교 가부시키가이샤 경도인지 장애의 치료 또는 예방용 융합 트리아졸
CA2817975C (en) * 2010-11-16 2020-03-31 Michael Kahn Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells
AP2014007606A0 (en) * 2011-10-07 2014-05-31 Takeda Pharmaceutical 1-Arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
CN119684295A (zh) * 2020-11-02 2025-03-25 雅斯娜制药公司 用于治疗疾病的双环化合物及其用途

Also Published As

Publication number Publication date
CL2024001748A1 (es) 2024-11-22
WO2023114456A1 (en) 2023-06-22
TW202339756A (zh) 2023-10-16
CA3240896A1 (en) 2023-06-22
KR20240121239A (ko) 2024-08-08
EP4448100A4 (en) 2025-10-22
US20250041307A1 (en) 2025-02-06
MX2024005884A (es) 2024-05-29
AU2022410646A1 (en) 2024-05-30
JP2024546600A (ja) 2024-12-26
EP4448100A1 (en) 2024-10-23

Similar Documents

Publication Publication Date Title
RU2009102535A (ru) Производные карбамидов тропана, их получение и их применение в терапии
CR20210602A (es) Compuestos de pirrolidina
MX2012003499A (es) Inhibidores de demetilasa-1 especificos de lisina y su uso.
RU2004109812A (ru) Ингибиторы цистеинпротеазы 2-циано-4-аминопиримидинового строения с ингибирующим действием на катепсин к для лечения воспалительных и других заболеваний
CA2497868A1 (en) Heterocyclic compounds
RU2017138972A (ru) Ингибиторы репликации вируса иммунодефицита человека
JP2018502877A5 (https=)
JP2018509418A5 (https=)
CA2582447A1 (en) Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
JP2006502119A5 (https=)
MXPA04009784A (es) Tiazolidin-4-carbonitrilos y analogos y su uso como inhibidores de dipeptidil-peptidas.
CA2503868A1 (en) Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors
WO2006078621A3 (en) 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders
AR045389A1 (es) Inhibidores del c-kit con estructura de pirazolil-amidil-benzoimidazolilo n-sustituido
ZA200603474B (en) Alkoxy substituted imidazoquinolines
SE0201937D0 (sv) Therapeutic agents
NO20082077L (no) Spirosykliske quinazolinderivater som PDE7-inhibitorer
RU2009144538A (ru) Новые циклические пептидные соединения
JP2005538111A5 (https=)
RU2435760C2 (ru) 1н-хиназолин-2,4-дионы
DE602004031338D1 (de) Isochinolin-1,3,4-trion, synthetisches verfahren und dessen verwendung
IL313039A (en) Uses of bicyclic compounds for the treatment of diseases
CA2592345A1 (en) Piperidine and azetidine derivatives as glyt1 inhibitors
NO20063330L (no) Amidderivater med en syklopropylaminokarbonylsubstituent som er nyttige som cytokininhibitorer
EA200500581A1 (ru) Производные пролина, обладающие сродством к альфа-2-дельта субъединице кальциевого канала